In a nutshell This study examined whether the newly developed ‘EUTOS’ score can predict treatment outcomes of imatinib (Gleevac) for chronic myeloid leukemia (CML). Researchers reported that the new ‘EUTOS’ score was associated with high predictive accuracy of treatment outcomes of imatinib. Some background In recent years,...
Read More
Home »
Treatment(s) already received-Biological therapy-Targeted Therapy
Treatment(s) already received-Biological therapy-Targeted Therapy Posts on Medivizor
To receive all the
cutting-edge updates personally relevant to you
(free and private)
Categories
- Benign prostatic hyperplasia
- Blog
- Breast cancer
- Cancer
- Colorectal cancer
- Coronary artery disease
- Coronavirus / COVID-19
- Diabetes mellitus
- Erectile dysfunction
- Hodgkin's lymphoma
- Hypertension
- Infertility
- Kidney stones
- Leukemia
- Lung cancer
- Lymphoma
- Melanoma
- Men's Health
- Mental Health
- Multiple Myeloma
- Nocturia
- Non-Hodgkin lymphoma
- Overactive bladder
- Parkinson's Disease
- Prostate cancer
- Rare disease
- Rheumatoid Arthritis
- Stroke
- Urinary incontinence
- Urinary tract infection
Recent Posts
- Movember: More than facial hair–men’s health!
- Unlocking A Mystery: Mast Cells, Hypermobile Ehlers-Danlos Syndrome, and Genes
- Periodontal Disease: Keep your teeth clean for better health
- Evaluating the pulsed solid-state Thulium: YAG laser in men with benign prostatic hyperplasia in a real-world setting
- Comparing the safety and effectiveness of hormonal therapy alone versus chemo-hormonal therapy before prostate surgery in men with locally advanced prostate cancer